Impact of a medico-pharmaceutical follow-up and an optimized communication between hospital and community on the readmission to the emergency department for an adverse drug event: URGEIM, study protocol for a randomized controlled trial

BACKGROUND: Adverse drug events (ADE) represent one of the main causes of admission to emergency department (ED). Their detection, documentation, and reporting are essential to avoid readmission. We hypothesize that a pharmacist-initiated multidisciplinary transition of care program combining ED pha...

Descripción completa

Detalles Bibliográficos
Autores principales: Breuker, Cyril, Faucanié, Marie, Laureau, Marion, Perier, Damien, Pinzani, Véronique, Marin, Grégory, Sebbane, Mustapha, Villiet, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349018/
https://www.ncbi.nlm.nih.gov/pubmed/34362410
http://dx.doi.org/10.1186/s13063-021-05501-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349018/
https://www.ncbi.nlm.nih.gov/pubmed/34362410
http://dx.doi.org/10.1186/s13063-021-05501-4

Ejemplares similares